RP Bio Inc. (KOSDAQ:314140)
South Korea · Delayed Price · Currency is KRW 6,140.00
-10.00 (-0.16%)
At close: May 8, 2026
RP Bio Market Cap
RP Bio has a market cap or net worth of 50.96 billion as of May 11, 2026. Its market cap has increased by 12.21% in one year.
Market Cap
50.96B
Enterprise Value
55.78B
Revenue
136.22B
Ranking
n/a
PE Ratio
10.87
Stock Price
6,140.00
Market Cap Chart
Since September 29, 2022, RP Bio's market cap has decreased from 143.18B to 50.96B, a decrease of -64.41%. That is a compound annual growth rate of -24.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 50.96B | -20.54% |
| Dec 30, 2025 | 64.13B | 46.53% |
| Dec 30, 2024 | 43.77B | -41.62% |
| Dec 28, 2023 | 74.96B | -26.88% |
| Dec 29, 2022 | 102.52B | -28.40% |
| Sep 29, 2022 | 143.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Optipharm.CO.,LTD | 75.84B |
| Sinil Pharmaceutical | 68.49B |
| Hwail Pharmaceutical | 67.85B |
| BL Pharmtech | 62.66B |
| Jin Yang Pharmaceutical | 61.58B |
| Korea Arlico Pharm | 53.26B |
| Kyung Nam Pharm | 52.36B |
| Eagle Veterinary Technology Co.,Ltd | 50.06B |